Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan |
July 2005
- 27 July 2005 Richardson, Texas
- Fujitsu Sponsors INPUT Federal Executive Breakfast on August 4, 2005 featuring Dr. Dan Mehan from the FAA
Richardson, Texas, July 27, 2005 – Fujitsu Network Communications Inc., a leading supplier of IT and wireline/wireless networking solutions, announced today that they are sponsoring the INPUT Federal Executive Breakfast on Thursday, August 4, 2005.
- 20 July 2005 Dublin
- CSO leads the way with new business reporting technology
Dublin, July 20, 2005 – The Central Statistics Office (CSO) Ireland has successfully piloted the use of a new business reporting technology, XBRL® (eXtensible Business Reporting Language), in one of its quarterly industry surveys. Fujitsu Software Corporation and PricewaterhouseCoopers worked with the CSO in developing this solution. This is the first live implementation of XBRL in Ireland. XBRL is a language which describes the content and structure of business reports, ranging from small form-based sets of data to full financial statements. XBRL facilitates the structuring of financial information in a manner that can be easily understood by computers. XBRL is XML based and facilitates the transmission, storage and processing of this information over the Internet.
- 19 July 2005 Frisco, TX
- Nordstrom Completes Rollout of Fujitsu POS Technology
Frisco, TX, July 19, 2005 – Fujitsu Transaction Solutions Inc. has completed the rollout of a point-of-sale (POS) technology replacement for Nordstrom, one of the nation's leading fashion specialty retailers.
- 11 July 2005 Westwood, Massachusetts
- The BioSciences Group of Fujitsu Unveils New in silico Technique for Enhanced ADME/Tox Predictions
Westwood, Massachusetts, July 11, 2005 – The BioSciences Group of Fujitsu Computer Systems today unveiled a new technique for generating enhanced predictions for ADME/Tox research, consisting of a unique docking-based approach combined with off-the-shelf and purpose-built technologies, to develop viable and effective predictive models. The new approach was developed with a commercial collaborator focusing on drug-resistant infectious diseases and cancer.
